TITUSVILLE, Fla., April 20, 2018 -- The Apple Rush Company, Inc. (OTCPINK:APRU) (the “Company”) is pleased to announce to its shareholders and partners, in what can only be described as a major coup, has signed an exclusive licensing and supply agreement with Global Nutraceuticals limited for use of its patented Agathos-Active, a natural African plant extract.
The Apple Rush Company's subsidiary APRU, LLC is a Florida based limited liability company that is a specialty manufacturer and co-packer of all natural and organic drinks, edibles, balms, tinctures, vapes, soaps, deodorants, coffees, with active ingredients ranging from hemp extracts, vitamins, caffeine, kratom, kava, melatonin, and others as needed by its customers.
Michael Duncombe Stander the CEO of Global quoted, “The use of this scientifically researched and patented natural extract, in combination with CBD oil will herald a new dawn in addressing pain/inflammation, and life style diseases such as diabetes, obesity and hypertension. It will provide a world first as a super natural alternative to opioids like never experienced before. Our high vacuum low steam extraction process is unique and provides far greater biological activity than any other means of extraction.”
Agathos–Active is a combination of extracts of the essential oils and acquis extracts of the Agathosma plant, approved by the FDA as a food additive, and has a documented medical history of over 300 years.
Global Nutraceuticals limited through its affiliated company network is a substantial producer (80%) of Agathos-Active, an organic and natural extract with potent and scientific pharmacological properties and health benefits. Global Nutraceuticals limited has been the sponsor of the most of the extensive scientific research that has been undertaken to establish the pharmacological properties of the Agathosma plant species.
Michael Duncombe Stander has been actively involved in the scientific research and development of the Agathos–Active plant extracts for over 20 years.
He will consult and provide scientific and technical knowledge to APRU during the course of the agreement.
Tony Torgerud CEO of APRU is quoted as saying “this licensing agreement with Global Nutraceuticals limited for supply of Agathos-Active provides APRU with an unequalled edge and opportunity over our competitors that are merely CBD active oil extracts.”
About Apple Rush Co, Inc. (APRU)
The Apple Rush Company, Inc. through its subsidiary APRU, LLC, Alternative Products Unlimited is a manufacturer of specialty supplements including Anhydrous Hemp Oil, Kratom, Kava, and other active ingredients. The supplement format is its proprietary soft cold processed chew. The company markets its products through private label, white label, and through distributors in the United States and internationally. The company was founded in 1998 and is now based in Titusville, FL. www.aprullc.com.
Investor Relations Contact
Tony Torgerud
714-940-0155


Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
Japan Earthquake Disrupts Auto and Chip Supply Chains
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Capital One Says AML Review Led to Closure of Trump Organization Accounts
Same sparkle, different story: how lab-grown diamonds are transforming the market 



